Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial

Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial

Abstract Background Pre-exposure prophylaxis (PrEP) is a promising strategy to break COVID-19 transmission. Although hydroxychloroquine was evaluated for treatment and post-exposure prophylaxis, it is not evaluated for COVID-19 PrEP yet. The aim of this study was to evaluate the efficacy and safety...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Berta Grau-Pujol, Daniel Camprubí-Ferrer, Helena Marti-Soler, Marc Fernández-Pardos, Clara Carreras-Abad, Maria Velasco-de Andrés, Elisabet Ferrer, Magdalena Muelas-Fernandez, Sophie Jullien, Giuseppe Barilaro, Sara Ajanovic, Isabel Vera, Laura Moreno, Eva Gonzalez-Redondo, Núria Cortes-Serra, Montserrat Roldán, Ana Artes-de Arcos, Isabel Mur, Pere Domingo, Felipe Garcia, Caterina Guinovart, Jose Muñoz
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Hydroxychloroquine
COVID-19
Pre-exposure prophylaxis
Prevention
Health-care workers
Control
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/2b4c20b3728740f1b490dccab7dd5a8a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/2b4c20b3728740f1b490dccab7dd5a8a

Documents similaires